中基長壽科學(00767.HK)擬配售及發行認購股份總籌2.13億港元用於收購公司發展長壽科學業務
格隆匯 5 月 11日丨中基長壽科學(00767.HK)發佈公吿,2021年5月10日,公司與配售代理(即基石證券有限公司)訂立配售協議,據此,公司已有條件同意透過配售代理盡力向不少於六名獨立承配人配售最多2.5億股配售股份,配售價為每股0.65港元。
該配售股份最高數目相當於本公吿日期公司已發行股本約6.46%及經配發及發行配售股份擴大的公司已發行股本約6.07%。配售價每股0.65港元較股份於最後交易日的聯交所所報收市價每股0.74港元折讓約12.16%。
同日,公司與認購人(即董事會主席兼執行董事閆立先生)訂立認購協議,據此,認購人已有條件同意認購而公司擬配發及發行的合共7700萬股認購股份,認購價為每股認購股份0.65港元(相等於配售價)。該認購股份相當於本公吿日期公司已發行股本約1.99%及經配發及發行配售股份及認購股份總數擴大的公司已發行股本約1.83%。
假設最高數目的配售股份及認購股份獲配售及認購,配售事項及認購事項的所得款項總額預計約為2.1255億港元(按配售價及認購價每股股份0.65港元計算)。配售事項及認購事項的所得款項淨額預計將不少於2.0749億港元。其中,約1.8億港元將用於收購公司發展長壽科學業務(包括公司日期4月8日及4月10日的公吿所披露的公司建議收購事項),而約2749萬港元則用作集團的一般營運資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.